Quest Diagnostics Files 2024 Proxy Statement

TL;DR

Quest Diagnostics DEF 14A is out, shareholders vote on directors & auditors May 16.

AI Summary

Quest Diagnostics Inc. filed its definitive proxy statement (DEF 14A) on April 5, 2024, for its annual meeting on May 16, 2024. The filing outlines the company's governance and executive compensation details for the fiscal year ending December 31, 2023. Key proposals will likely include the election of directors and the ratification of its independent registered public accounting firm.

Why It Matters

This filing provides shareholders with crucial information regarding company leadership, voting matters, and executive compensation, enabling informed decisions at the upcoming annual meeting.

Risk Assessment

Risk Level: low — This is a routine annual filing providing information to shareholders and does not indicate any immediate operational or financial risks.

Key Numbers

• 2023 — Fiscal Year End (Executive compensation and company performance details are reported for this period.)

Key Players & Entities

• Quest Diagnostics Inc. (company) — Registrant
• 0000930413-24-001247 (filing_id) — Accession Number
• 20240405 (date) — Filing Date
• 20240516 (date) — Meeting Date

FAQ

From the Filing

0000930413-24-001247.txt : 20240405 0000930413-24-001247.hdr.sgml : 20240405 20240405163312 ACCESSION NUMBER: 0000930413-24-001247 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 49 CONFORMED PERIOD OF REPORT: 20240516 FILED AS OF DATE: 20240405 DATE AS OF CHANGE: 20240405 FILER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 24826978 BUSINESS ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 DEF 14A 1 c108438_def14a-ixbrl.htm   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant [X] Filed by a Party other than the Registrant [_] Check the appropriate box:   [_] Preliminary Proxy Statement [_] CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (as permitted by Rule 14a-6(e)(2)) [X] Definitive Proxy Statement [_] Definitive Additional Materials [_] Soliciting Material Pursuant to Section 240.14a-12   Quest Diagnostics Incorporated   (Name of Registrant as Specified In Its Charter)   (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) Payment of Filing Fee (Check the appropriate box): [X]  No fee required [_]  Fee paid previously with preliminary materials [_]  Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11           Notice of 2024 Annual Meeting of Stockholders   and   Proxy Statement   April 5, 2024     The Quest Way       Purpose Why we exist   Working together to create a healthier world, one life at a time                 We help people make the best decisions to improve health by providing high-quality, innovative, convenient and affordable diagnostic testing insights and services using our scale and extensive reach   Strategy How we grow   • Collaborating with healthcare providers and partners to leverage our broad access     • Offering an industry-leading menu of testing and other services     • Leveraging our data assets and services to improve population health and enable value-based care       • Continuously improving our quality and efficiency by leveraging the Quest Management System and by embracing innovative technologies, such as automation and artificial intelligence (“AI”)       Who we serve: physicians, hospitals, patients and consumers, health plans, employers, emerging retail healthcare providers, government agencies, pharmaceutical companies and other commercial clinical laboratories                   Culture How we work   Customer first, Care, Collaboration, Continuous improvement, Curiosity               Notice of 2024 Annual Meeting of Stockholders Quest Diagnostics Incorporated One Insights Drive Clifton, New Jersey May 16, 2024, 10:30 a.m. Eastern Time   April 5, 2024   Dear Fellow Stockholder:   It is my pleasure to invite you to attend Quest Diagnostics’ 2024 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, stockholders will vote on the following, in addition to any other business as may properly come before the Annual Meeting or an